semaglutide and nafld Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? Dawn of an era of

During energy restriction, the body requires fuel and will mobilise stored reserves to meet its needs

Obesity: Overview and Impact Obesity has grown into a major global health issue, driven by an imbalance between energy intake and expenditure, leading to excess fat storage

Hansoh Pharma is becoming an emerging leader in metabolic diseases, and we see Mercks expertise and capabilities as key to accelerating the development of this promising asset for patients worldwide.

This regeneration isnt always sufficient to prevent loose skin following significant weight loss, as collagen and elastin depletion can still happen